Pay in 4 interest-free payments of $6.28 Learn more
Ships within 48 hours · Estimated delivery Aug 11 - Aug 16
Whether retatrutide's glucagon activity preferentially targets visceral fat versus other GLP-1-class drugs has not been tested head-to-head
Tirzepatide pens may be kept at room temperature up to 86F (30C) for a maximum of 21 days before use
Retatrutide is an investigational once-weekly injectable triple receptor agonist that activates GLP-1, GIP, and glucagon receptors simultaneously, producing greater appetite suppression and energy expenditure than single or dual receptor agonists
Abnormal: If the liquid is cloudy, discolored (yellowish or brownish), or has visible particles floating in it, discard it immediately
Furthermore, through antioxidant activity, copper peptides help neutralize free radicals and protect the skin from harmful effects, such as UV radiation and pollution
No immunogenic responses
